Abstract |
A 67-year-old woman was diagnosed with cecal cancer, para-aortic lymph node metastasis, peritoneum dissemination, and left breast cancer. We administered mFOLFOX6 plus panitumumab for cecal cancer and an aromatase inhibitor for her breast cancer. She received 7 courses of systemic chemotherapy and showed a partial response. She additionally received 5 courses of mFOLFOX6 plus panitumumab. We performed ileocecal resection, sigmoidectomy, right oophorectomy, dissection of the para-aortic lymph nodes, and peritoneal dissemination. The histopathological findings revealed adenocarcinoma, ypT3, ypN0, ycM0, ypStage II ( therapeutic effect Grade 2). One month later, she underwent an enforced left breast segmental resection and sentinel lymph node biopsy(0/2). The results of the pathological examination indicated no residual cancers ( therapeutic effect Grade 3). The patient is now in good health and was administered S-1 as an outpatient.
|
Authors | Kei Kimura, Masafumi Noda, Ayako Imada, Jihyung Song, Akihito Babaya, Michiko Hamanaka, Masayoshi Kobayashi, Kiyoshi Tsukamoto, Tomoki Yamano, Masataka Ikeda, Naohiro Tomita |
Journal | Gan to kagaku ryoho. Cancer & chemotherapy
(Gan To Kagaku Ryoho)
Vol. 44
Issue 12
Pg. 1293-1295
(Nov 2017)
ISSN: 0385-0684 [Print] Japan |
PMID | 29394611
(Publication Type: Case Reports, Journal Article)
|
Chemical References |
- Antibodies, Monoclonal
- Organoplatinum Compounds
- Panitumumab
- Leucovorin
- Fluorouracil
|
Topics |
- Aged
- Antibodies, Monoclonal
(administration & dosage)
- Antineoplastic Combined Chemotherapy Protocols
(administration & dosage, therapeutic use)
- Aorta
(pathology, surgery)
- Cecal Neoplasms
(drug therapy, pathology, surgery)
- Colectomy
- Female
- Fluorouracil
(administration & dosage)
- Humans
- Leucovorin
(administration & dosage)
- Lymphatic Metastasis
- Neoadjuvant Therapy
- Organoplatinum Compounds
(administration & dosage)
- Panitumumab
- Peritoneal Neoplasms
(drug therapy, secondary, surgery)
|